Accéder au contenu
Merck
  • Reduction of vanadium(V) to vanadium(IV) by NADPH, and vanadium(IV) to vanadium(III) by cysteine methyl ester in the presence of biologically relevant ligands.

Reduction of vanadium(V) to vanadium(IV) by NADPH, and vanadium(IV) to vanadium(III) by cysteine methyl ester in the presence of biologically relevant ligands.

Biochimica et biophysica acta (2007-06-19)
Mohammad K Islam, Chieko Tsuboya, Hiroko Kusaka, Sen-ichi Aizawa, Tatsuya Ueki, Hitoshi Michibata, Kan Kanamori
RÉSUMÉ

To better understand the mechanism of vanadium reduction in ascidians, we examined the reduction of vanadium(V) to vanadium(IV) by NADPH and the reduction of vanadium(IV) to vanadium(III) by L-cysteine methyl ester (CysME). UV-vis and electron paramagnetic resonance spectroscopic studies indicated that in the presence of several biologically relevant ligands vanadium(V) and vanadium(IV) were reduced by NADPH and CysME, respectively. Specifically, NADPH directly reduced vanadium(V) to vanadium(IV) with the assistance of ligands that have a formation constant with vanadium(IV) of greater than 7. Also, glycylhistidine and glycylaspartic acid were found to assist the reduction of vanadium(IV) to vanadium(III) by CysME.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
L-Cysteine methyl ester hydrochloride, 98%
Sigma-Aldrich
Gly-Asp, ≥99.0%
Sigma-Aldrich
Gly-His hydrochloride hydrate, ≥99.0% (calc. based on dry substance, AT)
Sigma-Aldrich
Gly-DL-Asp